SCHEMBL599589

SCHEMBL599589

CCCC(C)C(CC)CC

nearest known ligand 0.42

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
METAP1 P53582 1/20 0.37
TSHR P16473 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094600 0.91 LMNA (0.37) LMNAMETAP1TSHR
SCHEMBL3028361 0.90 LMNA (0.40) LMNAMETAP1TSHR
SCHEMBL1970569 0.85 LMNA (0.37) LMNAMETAP1TSHR
SCHEMBL598055 0.84 LMNA (0.40) LMNAMETAP1TSHR
SCHEMBL3438064 0.83 ALDH1A1 (0.37) LMNAMETAP1TSHR
SCHEMBL4946041 0.83 LMNA (0.58) LMNAMETAP1TSHR
SCHEMBL3386897 0.83 LMNA (0.36) LMNAMETAP1TSHR
SCHEMBL22664006 0.83 ALDH1A1 (0.37) LMNAMETAP1TSHR
SCHEMBL16264860 0.83 LMNA (0.36) LMNAMETAP1TSHR
SCHEMBL83902 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110372022-B One-step synthesis method of macroscopic 3D multi-stage porous nano material 河海大学 2021-10-19 CN claimed
CN-110528083-B Method for doping macroscopic 3D nano material 河海大学 2021-06-01 CN claimed
CN-110227435-B Macroscopic 3D high-porosity low-permeability nano catalytic material and preparation method thereof 河海大学 2021-06-01 CN claimed
CN-110528083-A The method of macroscopical 3D nano material doping UNIV HOHAI 2019-12-03 CN claimed
CN-110372022-A Macroscopical 3D multistage porous nanometer material one-step method for synthesizing 河海大学 2019-10-25 CN claimed
EP-2829555-B1 METHOD FOR PRODUCING OLEFIN POLYMER MITSUI CHEMICALS INC (JP) 2018-05-16 EP claimed
CN-104203993-B Process for producing olefin polymer 三井化学株式会社 2016-06-15 CN claimed
US-9315602-B2 Method for producing olefin polymer MITSUI CHEMICALS, INC. (JP) 2016-04-19 US claimed
US-12616728-B2 Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same SUPER CRITICAL IP, LLC (US) 2026-05-05 US disclosed
US-12454497-B2 Fuels and methods of making the same ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) 2025-10-28 US disclosed
US-20250152646-A1 SOLVENTS, METHODS, AND SYSTEMS FOR ISOLATING CANNABINOIDS FROM PLANTS EXTRACTS OR FROM SYNTHETIC PATHWAYS NOEL ARMAND J (US) 2025-05-15 US disclosed
US-20240368054-A1 FUELS AND METHODS OF MAKING THE SAME Alliance for Energy Innovation, LLC 2024-11-07 US disclosed
US-12090185-B2 Processes for converting cannabinoids into cannabinoid derivatives and recovering the same SUPER CRITICAL IP, LLC (US) 2024-09-17 US disclosed
EP-3907003-B1 HALOGEN-CONTAINING COMPOUND AND USE THEREOF AS CATALYST LIGAND IN ETHYLENE OLIGOMERIZATION CHINA PETROLEUM & CHEM CORP (CN) 2024-09-04 EP disclosed
EP-0089678-B1 NOVEL 2-BETA-D-RIBOFURANOSYLSELENAZOLE-4-CARBOXAMIDE COMPOUNDS AND METHODS FOR THEIR PRODUCTION BRIGHAM YOUNG UNIVERSITY (US) 1986-09-24 EP disclosed
US-4594416-A ANTITUMOR AGENTS, VIRICIDES BRIGHAM YOUNG UNIVERSITY (US) 1986-06-10 US disclosed
US-4594414-A VIRICIDES, ANTITUMOR A&ENTS BRIGHAM YOUNG UNIVERSITY (US) 1986-06-10 US disclosed
US-4531001-A 2-β-D-ribofuranosylselenazole-4-carboxamide compounds BRIGHAM YOUNG UNIVERSITY (US) 1985-07-23 US disclosed
EP-0089678-A1 Novel 2-beta-D-ribofuranosylselenazole-4-carboxamide compounds and methods for their production BRIGHAM YOUNG UNIVERSITY (US) 1983-09-28 EP disclosed
US-4117221-A AMINOACYL DERIVATIVES OF AMINOGLYCOSIDE ANTIBIOTICS SCHERING CORPORATION (US) 1978-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12454497-B2 Fuels and methods of making the same ACADM, SCD, FASN LMNA 2794/4885METAP1 4331/4885TSHR 3581/4885
US-12616728-B2 Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same CNR2, CNR1, SCD LMNA 408/4885METAP1 4478/4885TSHR 2794/4885
US-20240368054-A1 FUELS AND METHODS OF MAKING THE SAME ACADM, SCD, FASN LMNA 2794/4885METAP1 4331/4885TSHR 3581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.